A Randomized Trial of Tac/MTX/bortezomib vs Tac/MTXplacebo in Allogeneic HSCT

John Nicholas

BH3-only Protein Targeting by HHV-8

Non-Hodgkin lymphoma Hodgkin lymphoma

Pathology

Soheil Meshinchi

Biology and Prognostic Implications of FLT3 Mutations in AML

Leukaemia

Tait D Shanafelt

Predicting Clinical Outcome After Traditional and Ibrutinib-based Therapy In Chronic Lymphocytic Leukemia

Leukaemia

Hematology and hematologic malignancies

Hamid Band

Tyrosine Kinase Regulation Via Protein Degradation

Leukaemia

Hematology and hematologic malignancies Pathology

Jun J Yang

ARID5B and Disparities of Childhood Leukemia

Leukaemia

Hematology and hematologic malignancies Pediatric oncology or childhood cancer

David H Haussler

Center for Big Data in Translational Genomics

Leukaemia

Robert G Roeder

Function and targeting of a stable transcription factor complex in leukemia

Leukaemia

Scott Moore Carlson

The role of PRDM1 in epigenetic regulation and tumor suppression

Hodgkin lymphoma Leukaemia Non-Hodgkin lymphoma

Andrew M Evens

MAP Kinase Signaling in Lymphoma: A Novel Therapeutic Paradigm

Non-Hodgkin lymphoma

Pathology